Alaunos Therapeutics, Inc.
- Last sale
- Nov 12, 2026 · +3.73%
- Market cap
- $5.55M
- 3.32M shares
- Filings
- 1,028
Q3 2026−50.0% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026+26.9% FY25 yoy
- $5.55M
- —
- 1850.7×
- 5.7×
- —
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $5,000 | reported | |
| FY 2024 | 2024-12-31 | $10,000 | reported | |
| FY 2023 | 2023-12-31 | $5,000 | reported | |
| FY 2022 | 2022-12-31 | $2,922,000 | reported | |
| FY 2021 | 2021-12-31 | $398,000 | reported | |
| FY 2020 | 2020-12-31 | $0 | reported | |
| FY 2018 | 2018-12-31 | $146,000 | reported | |
| FY 2017 | 2017-12-31 | $6,389,000 | reported | |
| FY 2016 | 2016-12-31 | $6,861,000 | reported | |
| FY 2012 | 2012-12-31 | $800,000 | reported | |
| FY 2011 | 2011-12-31 | $667,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2023 | — | $0.00 | $0.00 | — | 16.01M sh | −93.3% | — |
| FY2022 | — | $45.00K | $45.00K | — | 240.63M sh | +11.3% | — |
| FY2021 | — | $0.00 | $0.00 | — | 216.13M sh | +0.7% | — |
| FY2019 | — | $653.00K | $653.00K | — | 213.00M sh | +31.2% | — |
| FY2018 | — | $1.62M | $1.62M | — | 162.29M sh | +14.0% | — |
Pharmaceutical preparations
Alaunos Therapeutics, Inc. is the 260th largest of the 552 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
IBOImpact Biomedical Inc.$32.0K—36,993.8%$41.5MTLPHTalphera, Inc.$28.0K—51,035.7%$53.5MJUNSJupiter Neurosciences, Inc.$21.8K—39,662.8%$3.0MSKVISkinvisible, Inc.$20.0K0.0%5,320.2%$1.1MBDPTBioadaptives, Inc.$18.3K44.3%8,523.4%$240.2KPRFXPRF Technologies Ltd.$17.0K—29,541.2%$606.3KGNLXGenelux Corp$8.0K0.0%401,812.5%$91.6MASBPAspire-Lakewood Holdings, Inc.$6.2K—394,725.1%$12.2M
TCRTAlaunos Therapeutics, Inc. (this company)$5.0K50.0%83,520.0%$5.6M
Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Alaunos Therapeutics, Inc. · CIK 1107421 · Engraved from SEC EDGAR